Anfotericina B Liposomal, Tratamiento Pediátrico en Leishmaniasis Cutánea con Falla Terapéutica.

The cutaneous leishmaniasis in Bolivia is less frequent in children. Its presence probably responds to the domestication of the vector in areas of human settlements. Amphotericin B is indicated for the treatment of leishmaniasis in adults, without response to pentavalent antimonials or without a cli...

Descripción completa

Detalles Bibliográficos
Publicado en:Gaceta Médica Boliviana Vol. 44; no. 2; pp. 254 - 260
Autores principales: Huanca Huanca, María Luz, Calderon Lopez, Maria Elena, Rojas Cabrera, Ernesto, Saavedra Borda, Carmen Rocío
Formato: Artículo
Publicado: Universidad Mayor de San Simon, Facultad de Medicina jul-dic2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=155479415&site=ehost-live
header:
  @attributes:
    shortDbName: lth
    uiTerm: 155479415
    longDbName: MedicLatina
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        10122966
        ECYT
      jtl: Gaceta Médica Boliviana
      issn: 10122966
      maglogo: N
    pubinfo:
      dt: jul-dic2021
      vid: 44
      iid: 2
      pid: 74695
      pub: Universidad Mayor de San Simon, Facultad de Medicina
    artinfo:
      ui:
        155479415
        10.47993/gmb.v44i2.320
      ppf: 254
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
            size: 586KB
      tig:
        atl: Anfotericina B Liposomal, Tratamiento Pediátrico en Leishmaniasis Cutánea con Falla Terapéutica.
      aug:
        au:
          Huanca Huanca, María Luz
          Calderon Lopez, Maria Elena
          Rojas Cabrera, Ernesto
          Saavedra Borda, Carmen Rocío
        affil:
          Hospital pediátrico Manuel Asencio Villarroel Cochabamba, Bolivia
          Centro Universitario de Medicina Tropical (CUMETROP), Facultad de Medicina, Universidad Mayor de San Simón. Cochabamba, Bolivia
          Universidad de la Republica Udelar, Montevideo, Uruguay
      sug:
      keyword:
        amphotericin B
        eficacy
        leishmaniasis cutaneous
        treatment outcome
        amphotericin B
        anfotericina B
        eficacia
        eficacy
        leishmaniasis cutánea
        leishmaniasis cutaneous
        resultado del tratamiento
        treatment outcome
      ab:
        The cutaneous leishmaniasis in Bolivia is less frequent in children. Its presence probably responds to the domestication of the vector in areas of human settlements. Amphotericin B is indicated for the treatment of leishmaniasis in adults, without response to pentavalent antimonials or without a clinical cure for ulcers. The objective of this series of cases is to share experiences of the use of liposomal amphotericin B in paediatric patients with cutaneous leishmaniasis and therapeutic failure of antimonials. Six patients with these characteristics admitted to the Infectology service of the Manuel Asencio Villarroel paediatric hospital, received liposomal Amphotericin B, 2 to 3 mg / kg weight day, in a mean period of 18 days. Progressive remission of the ulcers was observed during treatment and complete healing at three months of post-treatment. None had adverse effects, and the kidney and liver biochemical tests were within normal values.
        La leishmaniasis cutánea en Bolivia, es menos frecuente en niños. Su presencia probablemente responde a la domesticación del vector en áreas de asentamientos humanos. La anfotericina B, está indicada para el tratamiento de la leishmaniasis en adultos, sin respuesta a los antimoniales pentavalentes o sin una cura clínica de las úlceras. Esta serie de casos, tiene por objetivo compartir experiencias del empleo de anfotericina B liposomal en pacientes pediátricos con leishmaniasis cutánea y falla terapéutica a los antimoniales. Seis pacientes con estas características ingresados al servicio de Infectología del Hospital Pediátrico Manuel Asencio Villarroel, recibieron Anfotericina B liposomal 2 a 3 mg/Kg peso día, en un periodo promedio de 18 días. Se observó remisión progresiva de las úlceras durante el tratamiento y cicatrización completa a los tres meses post tratamiento. Ninguno presentó efectos adversos y las pruebas bioquímicas renales y hepáticas, se encontraban dentro de valores normales.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: Spanish
    refInfo:
    copyright:
      @attributes:
        flag: Y
      custom: Copyright of Gaceta Médica Boliviana is the property of Universidad Mayor de San Simon, Facultad de Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use.
      item: Gaceta Médica Boliviana
      holder: Universidad Mayor de San Simon, Facultad de Medicina
      dt:
        @attributes:
          year: 2021
    holdings:
      @attributes:
        islocal: N